ADAG
Adagene Inc.
NASDAQ · Healthcare · Biotechnology · CN
$3.58
−2.98%Margins
Gross margin
81.3%
EBITDA margin
-636.7%
EBIT margin
-689.1%
Net margin
-626.2%
FCF margin
-569.8%
-55.6%
Return on equity
-44.2%
Return on assets
-57.9%
Return on invested capital
0.09x
Asset turnover
-$53.5M
Cash from operations
$1.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026